ProAssurance (PRA) Proxy Filing summary

Executive summary

• Proposed acquisition by The Doctors Company announced, with a merger agreement signed on March 19, 2025.

• Employee communications and FAQs provided, with updates on transaction milestones and next steps.

• Forward-looking statements highlight expectations, risks, and uncertainties related to the transaction.

• Proxy statement to be finalized and mailed to stockholders, with a special meeting date to be set.

Voting matters and shareholder proposals

• Annual meeting on May 21 to elect directors, ratify auditors, and hold an advisory vote on executive compensation.

• No vote on the acquisition will occur at the annual meeting; a separate special meeting will be scheduled.

Board of directors and corporate governance

• Information about directors and executive officers, including their interests in the acquisition, will be disclosed in the proxy statement.

• Changes in security holdings by directors or officers will be reflected in Form 4 filings.